MedTrace Logo

The Role of Carotid Flow Time-Based Fluid Administration in Caesarean Section

NCT06048497 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2023-09-28

No results posted yet for this study

Summary

It has been reported that corrected carotid flow time (FTc) may indicate the responsiveness of spontaneously breathing patients to fluid therapy. The primary objective of the study is to determine the effect of fluid preload applied to patients with preanesthetic FTc values below the cut-off value on the incidence of hypotension in cesarean section (C/S) surgery. Pregnant women who underwent cesarean section under spinal anesthesia were included in this prospective study. In the preoperative care unit, patients were assigned to two groups according to their baseline FTc values. Patients with baseline FTc \< 327 ms were assigned to the first group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc \> 327 ms. On the other hand, patients with baseline FTc \> 327 ms were assigned to the second group, and preload fluid was not administered to these patients. Intraoperative hemodynamic data were recorded for each patient.

Conditions

  • Spinal Anesthesia
  • Cesarean Section

Interventions

DEVICE

Corrected carotid flow time measurement guided fluid preload

Preoperative FTcs of pregnant women who underwent C/S operation were measured, and those below the cut-off value (327 ms) determined in previous studies were preloaded with Ringer Lactate until FTc was \> 327 ms.

Sponsors & Collaborators

  • Cukurova University

    lead OTHER

Principal Investigators

  • Demet Laflı Tunay, Dr. · Çukurova University, Balcalı Hospital

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-15
Primary Completion
2023-05-20
Completion
2023-07-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06048497 on ClinicalTrials.gov